SCHEMBL21474041

SCHEMBL21474041

Cn1c(=O)n(-c2ccc(OCC(C)(C)O)nc2)c2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 3/20 0.38
▸ GAA P10253 1/20 0.36
▸ MTOR P42345 2/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ KCNJ5 P48544 1/20 0.35
▸ KCNJ3 P48549 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ BCL6 P41182 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ XBP1 P17861 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24405723 0.84 GAA (0.39) GAANPC1RAB9ALMNATSHR
SCHEMBL21474179 0.82 GAA (0.39) GAAMTORNPC1RAB9ALMNA
SCHEMBL23119712 0.81 GAA (0.40) GAAPIK3CANPC1RAB9ALMNA
SCHEMBL30615457 0.79 TNKS (0.40) MCHR1GAANPC1LMNASMN1; SMN2
SCHEMBL21463426 0.79 TNKS (0.40) MCHR1GAANPC1LMNASMN1; SMN2
SCHEMBL24405756 0.77 GAA (0.39) GAAPIK3CANPC1RAB9ALMNA
SCHEMBL29026387 0.75 PGR (0.38) GAAMTORPIK3CDPIK3CAPIK3CG
SCHEMBL24405558 0.74 PGR (0.43) MTORPIK3CDPIK3CAPIK3CGNPC1
SCHEMBL24405534 0.74 PGR (0.38) MTORPIK3CDPIK3CAPIK3CGPGR
SCHEMBL24405718 0.73 PIK3CD (0.36) GAAMTORPIK3CDPIK3CAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 — — EP disclosed
WO-2019198692-A1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC. (JP) 2019-10-17 — — WO disclosed
Send feedback